Chemotherapy treatments, costs of care, and survival for patients diagnosed with small cell lung cancer: A SEER‐Medicare study

OBJECTIVES: The effectiveness and costs of new treatments should be assessed in relation to existing practice. We describe treatments, survival and costs for advanced or metastatic small cell lung cancer (SCLC) patients receiving systemic therapy in the period preceding the introduction of immunothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Changxia, He, Jinghua, Kachroo, Sumesh, Jin, Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912057/
https://www.ncbi.nlm.nih.gov/pubmed/31668011
http://dx.doi.org/10.1002/cam4.2626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912057/
https://www.ncbi.nlm.nih.gov/pubmed/31668011
http://dx.doi.org/10.1002/cam4.2626

Ejemplares similares